Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Omega‐3 fatty acids (from fish oils) for cystic fibrosis

This is not the most recent version

Information

DOI:
https://doi.org/10.1002/14651858.CD002201.pub2Copy DOI
Database:
  1. Cochrane Database of Systematic Reviews
Version published:
  1. 17 October 2007see what's new
Type:
  1. Intervention
Stage:
  1. Review
Cochrane Editorial Group:
  1. Cochrane Cystic Fibrosis and Genetic Disorders Group

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Article metrics

Altmetric:

Cited by:

Cited 0 times via Crossref Cited-by Linking

Collapse

Authors

  • Colleen Oliver

    Correspondence to: Nutrition & Dietetics, Sydney Children's Hospital, Sydney, Australia

    [email protected]

    [email protected]

  • Mark Everard

    Department of Paediatrics, Sheffield Children's Hospital, Sheffield, UK

  • Tracy N'Diaye

    Clinical Research Facility, Sheffield Children's NHS FT, Sheffield, UK

Contributions of authors

Original review
NBW formulated the question, was primarily responsible for development of the protocol and writing the original review. NBW and TN'D selected the studies, graded the quality and extracted the data.

ME was consulted at all stages of the review, providing advice and support when needed.

Updates from 2007
Following the death of the lead author NBW, CM has taken on the lead and acts as guarantor of the review from 2007. The methodological quality of the included studies was re‐assessed by CM using the criteria described by Jüni (Jüni 2001).

Sources of support

Internal sources

  • Sheffield Children's Hospital Appeal, UK.

External sources

  • No sources of support supplied

Declarations of interest

None known.

Acknowledgements

We gratefully acknowledge the assistance of Sheffield Children's Hospital Appeal funding, which has supported the undertaking of the initial version of this review.

We acknowledge the considerable input into the production of the protocol and initial review of the former lead author, Naomi Beckles‐Wilson.

Version history

Published

Title

Stage

Authors

Version

2020 Apr 10

Omega‐3 fatty acid supplementation for cystic fibrosis

Review

Helen Watson, Caroline Stackhouse

https://doi.org/10.1002/14651858.CD002201.pub6

2016 Jan 05

Omega‐3 fatty acids for cystic fibrosis

Review

Colleen Oliver, Helen Watson

https://doi.org/10.1002/14651858.CD002201.pub5

2013 Nov 27

Omega‐3 fatty acids for cystic fibrosis

Review

Colleen Oliver, Helen Watson

https://doi.org/10.1002/14651858.CD002201.pub4

2011 Aug 10

Omega‐3 fatty acids for cystic fibrosis

Review

Colleen Oliver, Nikki Jahnke

https://doi.org/10.1002/14651858.CD002201.pub3

2007 Oct 17

Omega‐3 fatty acids (from fish oils) for cystic fibrosis

Review

Colleen Oliver, Mark Everard, Tracy N'Diaye

https://doi.org/10.1002/14651858.CD002201.pub2

2002 Jul 22

Omega‐3 fatty acids (from fish oils) for cystic fibrosis

Review

Naomi R Beckles‐Willson, T Elliott, Mark Everard, Tracy N'Diaye

https://doi.org/10.1002/14651858.CD002201

PICOs

Population
Intervention
Comparison
Outcome

The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.

See more on using PICO in the Cochrane Handbook.